TARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 21 NGS Genetic DNA Test
Understanding TARS2 Gene Testing
The TARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 21 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for rare metabolic disorders. This specialized test focuses on identifying mutations in the TARS2 gene, which plays a crucial role in mitochondrial protein synthesis and cellular energy production. Combined Oxidative Phosphorylation Deficiency Type 21 is a severe condition affecting multiple organ systems, making early detection essential for proper management and treatment planning.
What This Test Detects
Our advanced NGS technology precisely identifies:
- Pathogenic variants in the TARS2 gene affecting mitochondrial function
- Mutations disrupting oxidative phosphorylation processes
- Genetic abnormalities impacting cellular energy metabolism
- Inheritance patterns for family planning considerations
- Specific genetic markers associated with disease severity
Who Should Consider This Test
This genetic test is recommended for individuals presenting with:
- Unexplained developmental delays in infancy or childhood
- Neurological symptoms including seizures or movement disorders
- Metabolic abnormalities detected through routine screening
- Family history of mitochondrial disorders or unexplained infant deaths
- Progressive muscle weakness or exercise intolerance
- Failure to thrive despite adequate nutrition
- Multiple organ system involvement without clear diagnosis
Key Benefits of TARS2 Gene Testing
- Early Diagnosis: Enables timely intervention and management strategies
- Family Planning: Provides crucial information for genetic counseling
- Personalized Treatment: Guides targeted therapeutic approaches
- Prognostic Information: Helps predict disease progression and outcomes
- Peace of Mind: Reduces diagnostic uncertainty for families
Understanding Your Test Results
Our comprehensive genetic counseling ensures you fully understand your results:
- Positive Result: Indicates presence of TARS2 gene mutation, requiring specialized medical management
- Negative Result: Suggests absence of tested mutations, though other genetic causes may exist
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Important information for reproductive planning and family members
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.
Take Action Today
Don’t wait to get the answers you need. Our genetic specialists are ready to help you understand your risk and provide comprehensive testing services. Call us today at +1(267) 388-9828 to schedule your TARS2 Gene Combined Oxidative Phosphorylation Deficiency Type 21 NGS Genetic DNA Test and take the first step toward clarity and proper medical management.
Turnaround Time: 3 to 4 Weeks
Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
Specialty: General Physician & Genetics
Method: NGS Technology
Disease Type: Metabolic Disorders
